Working… Menu
Trial record 1 of 1 for:    rexlemestrocel-L | Heart Failure
Previous Study | Return to List | Next Study

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure. (DREAM HF-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02032004
Recruitment Status : Active, not recruiting
First Posted : January 9, 2014
Last Update Posted : April 5, 2019
Information provided by (Responsible Party):
Mesoblast, Ltd. ( Mesoblast, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019